Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Integrated Diagnostics Holdings ( (GB:IDHC) ) has shared an announcement.
Integrated Diagnostics Holdings announced it will release its unaudited financial results for Q3 and the nine-month period ending September 30, 2025, on November 13, 2025. This announcement is significant for stakeholders as it reflects the company’s ongoing financial performance and strategic positioning in the diagnostics industry, particularly in the Middle East and Africa, where it continues to expand its operations and market presence.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent diagnostics services provider in the Middle East and Africa, offering a wide range of clinical pathology and radiology tests across Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. With over 40 years of experience, IDH operates through core brands such as Al Borg, Al Borg Scan, and Al Mokhtabar in Egypt, Biolab in Jordan, Echo-Lab in Nigeria, and others. The company is known for its quality and safety standards, serving millions of patients through its extensive network of branches, and is listed on the London Stock Exchange.
Average Trading Volume: 205,957
Technical Sentiment Signal: Buy
Current Market Cap: $325.5M
See more data about IDHC stock on TipRanks’ Stock Analysis page.